1–1 of 1 result for X-linked retinitis pigmentosa (XLRP)
Subretinal Laru-zova Gene Therapy for XLRP: 24-Month Results of the Randomized, Controlled, Multicenter Phase 2 SKYLINE Trial
Robert Andrew Sisk, MD, FACS, FASRS
Annual Meeting Talks
2025